NOOTROPYL 3 g/15 ml, solution for injection in an ampoule 4 ampoules of 15 ml
Brand page: Nootropyl (piracetam) — all forms and strengths in France
Active ingredients: PIRACÉTAM
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection4 ampoules of 15 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NOOTROPYL 3 g/15 ml, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 4 ampoule(s) en verre de 15 ml
- Marketing authorisation holder
- UCB PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Nov 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67408144CIP73464792CIP133400934647925Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PIRACÉTAMsolution | 1 g · 5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.